Pradaxa Lawsuit Information
While bleeding that may lead to serious or even fatal outcomes is a known side effect of all anticoagulant drugs, research has shown that patients taking Pradaxa may face a higher-than-expected risk of severe bleeding complications, and because there is no approved antidote for Pradaxa, these bleeding events can sometimes be deadly. As a result of these findings, thousands of former Pradaxa users across the country have filed product liability lawsuits against Boehringer Ingelheim, and in May 2014, the drug company agreed to pay $650 million to settle more than 4,000 complaints brought over Pradaxa injuries and deaths.
Pradaxa lawsuits filed against Boehringer Ingelheim allege that the drug manufacturer failed to provide adequate warnings about the potential for the anticoagulant medication to cause serious or deadly bleeding complications in users. Plaintiffs also accuse the manufacturing company of overstating the benefits of Pradaxa in its marketing materials, claiming that the blood thinner was safer, easier and more convenient than warfarin, when, in fact, studies have linked Pradaxa to a higher risk of heart attacks, heart disease and other serious health complications compared with warfarin.